Program Type
Disease
Project Status

Displaying 176 - 191 of 191

All of Us Scholars Program
The FNIH is aligned with our colleagues at the NIH in efforts to improve diversity in the biomedical research workforce through training opp...
AMP Autoimmune & Immune-Mediated Diseases
The Accelerating Medicines Partnership® (AMP®) Program Autoimmune and Immune-Mediated Diseases (AMP AIM) is a precompetitive partnership t...
AMP Alzheimer’s Disease 1.0
The Accelerating Medicines Partnership® (AMP®) Program Alzheimer’s disease (AMP AD) was the first stage of a precompetitive partnership ...
AMP Schizophrenia 
The Accelerating Medicines Partnership® (AMP®) Program Schizophrenia (AMP SCZ) is the first neuropsychiatric project of the landmark AMP p...
AMP Parkinson’s Disease
The Accelerating Medicines Partnership® (AMP®) Program Parkinson’s disease (AMP PD) is a public-private partnership among NIH and privat...
AMP Heart Failure
The Accelerating Medicines Partnership® Heart Failure program (AMP® HF) is focused on a major unmet need in cardiovascular health. AMP HF ...
AMP Alzheimer’s Disease 2.0
The Accelerating Medicines Partnership® (AMP®) Program Alzheimer’s disease (AMP AD 2.0) is a precompetitive public-private partnership t...
AMP® Bespoke Gene Therapy Consortium (BGTC)
The Accelerating Medicines Partnership® (AMP®) Program Bespoke Gene Therapy Consortium (AMP BGTC) brings together partners from the public...
Data Portals
Rapid data dissemination is integral to the success of the AMP program. Many AMP projects have made large amounts of data and analytical too...
Accelerating Medicines Partnership® (AMP®)
Our mission is to improve understanding of disease pathways, facilitate better selection of targets for treatment and identify platforms and...

Diseases

Partner With Us